CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

PTC Therapeutics (NASDAQ:PTCT) is scheduled to announce Q2 earnings results on Thursday, August 7th, after market close. The ...

Hemispherian's GLIX1 gains FDA approval for glioblastoma trials, promising a novel therapy targeting DNA repair in tumor ...

– Dosing ongoing and planned in a handful of Other Serious Diseases (OSD) – – On track for first Biologics License Application (BLA) approved cell therapy in lead indication relapsed/refractory AL ...

Purespring Therapeutics has received approval for its UK clinical trial application (CTA) for a Phase I/II trial of its lead ...

Shanghai, China –August 6, 2025 – Everest Medicines (HKEX 1952,“Everest”, or the Company), a biopharmaceutical company focused on the discovery, cl ...